YN
Yigal Nochomovitz Citigroup Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
71
Avg Return
Past Year
Past Year
13%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
83.3%
Neutral
13.6%
Negative
3%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $8 |
403%
upside
| 1 | -21% |
0
%
| 3 Nov ‘25 7 months ago |
|
|
|
Buy
Maintained
| $46 |
132%
upside
| 1 | -28% |
0
%
| 28 Oct ‘25 7 months ago |
|
|
|
Buy
Maintained
| $40 |
186%
upside
| 2 | -9% |
0
%
| 20 Oct ‘25 7 months ago |
|
|
|
Neutral
Downgraded
| $97 |
8%
upside
| 1 | +54% |
–
| 29 Sep ‘25 8 months ago |
|
|
|
Buy
Maintained
| $69 |
304%
upside
| 1 | -46% |
0
%
| 11 Aug ‘25 10 months ago |
|
|
|
Buy
Maintained
| $22 |
4%
downside
| 1 | +97% |
0
%
| 11 Aug ‘25 10 months ago |
|
|
|
Buy
Maintained
| $52 |
668%
upside
| 3 | -14% |
0
%
| 1 Aug ‘25 10 months ago |
|
|
|
Buy
Maintained
| $9 |
449%
upside
| 1 | -42% |
0
%
| 9 Jul ‘25 11 months ago |
|